ES2137634T3 - Analogos de la 15-deoxispergualina, su procedimiento de preparacion y su uso en terapeutica. - Google Patents

Analogos de la 15-deoxispergualina, su procedimiento de preparacion y su uso en terapeutica.

Info

Publication number
ES2137634T3
ES2137634T3 ES96400949T ES96400949T ES2137634T3 ES 2137634 T3 ES2137634 T3 ES 2137634T3 ES 96400949 T ES96400949 T ES 96400949T ES 96400949 T ES96400949 T ES 96400949T ES 2137634 T3 ES2137634 T3 ES 2137634T3
Authority
ES
Spain
Prior art keywords
preparation procedure
deoxispergualine
therapeutics
analogs
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96400949T
Other languages
English (en)
Inventor
Luc Lebreton
Patrice Renaut
Christine Dumas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fournier Industrie et Sante SAS
Original Assignee
Fournier Industrie et Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Industrie et Sante SAS filed Critical Fournier Industrie et Sante SAS
Application granted granted Critical
Publication of ES2137634T3 publication Critical patent/ES2137634T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/14—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO COMPUESTO QUE SE ELIGE ENTRE EL CONJUNTO CONSTITUIDO POR: (I) LOS COMPUESTOS DE FORMULA: EN LA QUE A REPRESENTA UN GRUPO -CO-NH- O UN GRUPO -NHCO-, R REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METILO, C REPRESENTA, CUANDO R NO ES EL ATOMO DE HIDROGENO, UN CARBONO ASIMETRICO (R,S) O (R), Y (II) SUS SALES DE ADICION. SE REFIERE TAMBIEN AL PROCEDIMIENTO DE PREPARACION Y A LA UTILIZACION TERAPEUTICA DE ESTE COMPUESTO.
ES96400949T 1995-05-17 1996-05-03 Analogos de la 15-deoxispergualina, su procedimiento de preparacion y su uso en terapeutica. Expired - Lifetime ES2137634T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505862A FR2734263B1 (fr) 1995-05-17 1995-05-17 Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique

Publications (1)

Publication Number Publication Date
ES2137634T3 true ES2137634T3 (es) 1999-12-16

Family

ID=9479086

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96400949T Expired - Lifetime ES2137634T3 (es) 1995-05-17 1996-05-03 Analogos de la 15-deoxispergualina, su procedimiento de preparacion y su uso en terapeutica.

Country Status (22)

Country Link
US (1) US5733928A (es)
EP (1) EP0743300B1 (es)
JP (1) JP2860778B2 (es)
KR (1) KR960041153A (es)
CN (1) CN1063744C (es)
AT (1) ATE182882T1 (es)
AU (1) AU694342B2 (es)
CA (1) CA2176670C (es)
CZ (1) CZ292373B6 (es)
DE (1) DE69603541T2 (es)
DK (1) DK0743300T3 (es)
ES (1) ES2137634T3 (es)
FR (1) FR2734263B1 (es)
GR (1) GR3031684T3 (es)
HU (1) HUP9601323A3 (es)
NO (1) NO306397B1 (es)
NZ (1) NZ286582A (es)
RU (1) RU2130015C1 (es)
SK (1) SK283372B6 (es)
TW (1) TW354782B (es)
UA (1) UA42798C2 (es)
ZA (1) ZA963775B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843995A (en) * 1997-07-07 1998-12-01 University Of Medicine And Dentistry Of New Jersey Inhibition of HIV-1 replication using oligocarbamate derivatives
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
US4990536A (en) * 1989-04-03 1991-02-05 Nippon Kayaku Kabushiki Kaisha Immunopotentiator and spergualin-related compound therefor
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716452B1 (fr) * 1994-02-24 1996-05-10 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Also Published As

Publication number Publication date
FR2734263A1 (fr) 1996-11-22
DK0743300T3 (da) 2000-01-24
CA2176670C (en) 2002-03-26
SK63696A3 (en) 1996-12-04
DE69603541D1 (de) 1999-09-09
AU5208196A (en) 1996-11-28
DE69603541T2 (de) 2000-04-06
NO961891D0 (no) 1996-05-10
GR3031684T3 (en) 2000-02-29
TW354782B (en) 1999-03-21
EP0743300B1 (fr) 1999-08-04
EP0743300A1 (fr) 1996-11-20
CZ292373B6 (cs) 2003-09-17
CA2176670A1 (en) 1996-11-18
KR960041153A (ko) 1996-12-19
NO306397B1 (no) 1999-11-01
US5733928A (en) 1998-03-31
NZ286582A (en) 1998-07-28
HUP9601323A3 (en) 1998-04-28
HU9601323D0 (en) 1996-07-29
SK283372B6 (sk) 2003-06-03
CZ142396A3 (en) 1997-02-12
UA42798C2 (uk) 2001-11-15
ATE182882T1 (de) 1999-08-15
RU2130015C1 (ru) 1999-05-10
CN1063744C (zh) 2001-03-28
JPH0977733A (ja) 1997-03-25
ZA963775B (en) 1996-11-25
HUP9601323A2 (en) 1997-05-28
CN1143075A (zh) 1997-02-19
NO961891L (no) 1996-11-18
JP2860778B2 (ja) 1999-02-24
AU694342B2 (en) 1998-07-16
FR2734263B1 (fr) 1997-06-20

Similar Documents

Publication Publication Date Title
DK0595851T3 (da) Fremgangsmåde til fremstilling af sertralin-mellemprodukter
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
FI961506A (fi) Distamysiini A -analogit antituumorisina ja antiviraalisina aineina
ES2188957T3 (es) N-(4-(heteroarilmetil)fenil)-heteroarilaminas.
ES2037243T3 (es) Tiazolidindionas como agentes hipoglicemicos y anti-ateroscleroticos.
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ATE109466T1 (de) Neue derivate des aminopiperidins, aminopyrrolidins und des aminoperhydroazepins, verfahren zur herstellung und diese enthaltende arzneimittel.
AR000039A2 (es) Compuestos de piridinosulfonamida sustituidos, composiciones herbicidas que los contienen, metodo para preparar estos compuestos y compuestosintermediarios.
CO4130326A1 (es) Nuevos derivados de 2-ciano-1,3-diona, composiciones que los contienen, procedimientos para su preparacion y su uso como herbicidas
NO831095L (no) Spiro (4.(3+n))-2-aza-3-karboksylsyre-derivater, fremgangsmaate til deres fremstilling, midler som inneholder dem, og deres anvendelse
ES2070175T3 (es) Derivados de acido 4-oxoquinolino-3-carboxilico, su preparacion y su uso.
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
CO4990965A1 (es) Derivados de 1,3,8-triazaspiro(4,5)decan-4-ona to que los contiene y un proceso para la preparacion de es- tos derivados
DK0594666T3 (da) Fremgangsmåde til fremstilling af sertralin
ES2137634T3 (es) Analogos de la 15-deoxispergualina, su procedimiento de preparacion y su uso en terapeutica.
CO4520266A1 (es) Derivado de 1,3-oxazin-4-ona, el herbicida que lo contiene y los productos intermedios para prepararlo
MX9305932A (es) Derivados de piperidina, su preparacion y su aplicacion en terapeutica.
SV1999000075A (es) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenemetil)-cefemos
AR240859A2 (es) Composicion herbicida que contiene un derivado de difenil eter, dicho compuesto y procedimiento paraprepararlo
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR047470A1 (es) Derivados de pirrolo-pirimidina utiles para el tratamiento de enfermedades proliferativas,composiciones farmaceuticas que los contienen,y procesos para su preparacion
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
CR6503A (es) Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 743300

Country of ref document: ES